Mediolanum International Funds LTD Neurocrine Biosciences Inc Transaction History
Mediolanum International Funds LTD
- $7.18 Trillion
- Q3 2024
A detailed history of Mediolanum International Funds LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 59,902 shares of NBIX stock, worth $7.39 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
59,902
Previous 46,093
29.96%
Holding current value
$7.39 Million
Previous $5.78 Billion
19.06%
% of portfolio
0.1%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
624Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$635 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$317 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$230 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...